Effectiveness and safety of common therapeutic drugs for refractory lupus nephritis: A network meta-analysis.

In conclusion, the regimen of CTX + TAC + GC exhibited a trend in superiority regarding clinical efficacy among common therapeutic drug treatments for RLN, while the regimen of CTX + GC had a higher probability to cause adverse effects among the nine interventions compared. PMID: 31897105 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31897105?dopt=Abstract

Source: Experimental and Therapeutic Medicine - January 4, 2020 Category: General Medicine Tags: Exp Ther Med Source Type: research